Real-Time PCR Detection of the Basidiomycetous Fungus Bjerkandera adusta: A Tool to Identify Itraconazole Responder Patients with Unexplained Chronic Cough

Respiration. 2019;97(1):84-91. doi: 10.1159/000492118. Epub 2018 Oct 19.

Abstract

Background: Filamentous basidiomycetes (f-BMs) are involved in some unexplained chronic cough (UCC) cases that can be improved by the administration of antifungal agents. The disease concept was termed fungus-associated chronic cough (FACC). The current diagnostic criteria warrant environmental fungi isolation from respiratory specimens, which is hardly conceivable for such fungi.

Objectives: This study aimed to detect the f-BMs Bjerkandera adusta, the most common pathogen in FACC, from respiratory specimens of patients with UCC using real-time polymerase chain reaction (PCR). It also evaluated the applicability of the PCR system to detect antifungal agent responders among patients with unexplained cough.

Methods: The PCR system specific to B. adusta was developed and its utility was evaluated using sputum samples from 23 patients with chronic cough.

Results: B. adusta was detected in 10 out of 14 patients with UCC (71.4%), in contrast to only 2 out of 9 patients with non-UCC (22.2%; p < 0.05 with the Fisher's exact test). The copy number of the samples correlated with the therapeutic impact score for cough symptoms following the oral administration of itraconazole.

Conclusion: Development of the real-time PCR system enabled us to demonstrate that many patients with UCC might be influenced by B. adusta, a fact evidenced by the improvement of symptoms with itraconazole administration in most PCR-positive patients. This method would help in detecting itraconazole responders among patients with UCC when the isolation of f-BMs is not achievable.

Keywords: Bjerkandera adusta; Chronic cough; Filamentous basidiomycetes; Fungus-associated chronic cough; Quantitative real-time PCR method.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Antifungal Agents / therapeutic use
  • Chronic Disease
  • Coriolaceae / genetics*
  • Coriolaceae / isolation & purification
  • Cough / diagnosis*
  • Cough / drug therapy
  • Cough / microbiology
  • DNA, Fungal / analysis*
  • Feasibility Studies
  • Female
  • Follow-Up Studies
  • Humans
  • Itraconazole / therapeutic use*
  • Male
  • Middle Aged
  • Real-Time Polymerase Chain Reaction / methods*
  • Reproducibility of Results
  • Retrospective Studies
  • Sputum / microbiology*

Substances

  • Antifungal Agents
  • DNA, Fungal
  • Itraconazole